Project 2: Defining the Protective vs. Susceptible Immune Proteome of S. aureus Osteomyelitis
项目 2:定义金黄色葡萄球菌骨髓炎的保护性与易感性免疫蛋白质组
基本信息
- 批准号:10247796
- 负责人:
- 金额:$ 32.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-20 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelAntibodiesAntigensAutoimmunityAutolysinBacteriaBindingBiological AssayBloodCessation of lifeClinicalComplexCustomDataDiabetes MellitusEndocytosisEquus caballusEventFc domainFibrinogenGenus staphylococcusGoalsHaptoglobinsHemoglobinHumanHumoral ImmunitiesImmuneImmune responseImmunologic TestsImplantIn VitroIncidenceInfectionInterventionIntracellular TransportIronJoint ProsthesisKidneyKnowledgeLabelLeukocytesLiverLysoTrackerMediatingModelingMolecularMonoclonal AntibodiesMultiple Organ FailureMusObesityOperative Surgical ProceduresOrganOsteomyelitisOutcomePassive ImmunizationPatientsPilot ProjectsPredispositionProteinsProteomeRegistriesReplacement ArthroplastySepsisSiteSpleenStaphylococcal Protein AStaphylococcus aureusStaphylococcus aureus infectionStaphylococcus epidermidisStreamSurgical Wound InfectionTechnologyTestingTherapeutic immunosuppressionTimeTissue BanksTranslatingTranslational ResearchTraumabactericidefluorescence imagingin vivoindexingjoint infectionmacrophagemanosteoimmunologyprogramsrespiratoryseptictheories
项目摘要
Abstract
Prosthetic joint infection (PJI) is the bane of elective total joint replacement (TJR) surgery, of
which the vast majority is caused by Staphylococcal species. The 1-5% incidence of PJI is known to be
a nonrandom event that is largely determined by patient specific factors. Moreover, ~13% of patients
infected with S. aureus become septic and die from multiorgan failure, while others recover with little
intervention. In addition to the established host susceptibility factors, there are two leading theories to
explain this. The first is the “immune proteome” hypothesis, which posits that the array of specific
antibodies a host develops against S. aureus dictates its susceptibility vs. protection to infection. The
second is the “Trojan horse” model of S. aureus dissemination, in which leukocytes get infected at the
surgical site, and transport intracellular bacteria to the blood stream and internal organs, culminating in
septic death of susceptible hosts. Currently, there is no direct experimental or clinical evidence to
support these theories. However, we recently made several potential breakthrough discoveries that
substantiate these models. The first is that antibodies against the autolysin (Atl) proteins efficiently
induce megacluster formation, opsonophagocytosis, and protection/survival following S. aureus
osteomyelitis in mice and humans. The second is that iron sensing determinant B (IsdB) is the most
immuno-dominant S. aureus antigen in mouse and man, and that antibodies against IsdB are
associated with sepsis, multiorgan failure and death following surgical site infection.8,13 Here we
propose to: 1) elucidate the molecular mechanism of anti-IsdB mediated septic death, 2) validate the
“susceptible” anti-Isd vs. “protective” anti-Atl immune proteome in PJI patients, and 3) extend this
osteoimmunology to elucidate the immune proteomes of S. epidermidis and S. lugdunensis. Our
approaches to achieve these goals are embodied by three Specific Aims. In Aim 1 we will elucidate
the mechanism of anti-IsdB and related anti-IsdA and anti-IsdH antibody mediated sepsis following S.
aureus osteomyelitis. We will also complete a clinical pilot study to demonstrate that osteomyelitis
patients who succumb to S. aureus septic death have high anti-Isd titers and Trojan horse
macrophages in their blood and internal organs. In Aim 2 we will test the immune proteome hypothesis
by correlating anti-Isd and anti-Atl titers with the clinical outcomes of 300 PJI patients that undergo 2-
stage revision surgery using our multiplex-Luminex assay, and define the susceptible:protective index
of these immune proteomes. And in Aim 3 we will extend our knowledge of the mammalian host
response to Staphylococcus species by generate multiplex-Luminex assays for S. epidermidis and S.
lugdunensis, and uses them to screen sera from mice and PJI patients as we have done for S. aureus.
!
抽象的
人工关节感染 (PJI) 是选择性全关节置换 (TJR) 手术的祸根
其中绝大多数是由葡萄球菌引起的。已知 PJI 的发病率为 1-5%。
这是一个非随机事件,很大程度上由患者的具体因素决定,此外,约 13% 的患者。
感染金黄色葡萄球菌的人会出现败血症并死于多器官衰竭,而其他人则几乎不需要什么就能康复。
除了已确定的宿主易感因素外,还有两种主要理论可以进行干预。
第一个是“免疫蛋白质组”假说,该假说假设一系列特定的蛋白质。
宿主针对金黄色葡萄球菌产生的抗体决定了其对感染的易感性与保护性。
第二个是金黄色葡萄球菌传播的“特洛伊木马”模型,其中白细胞在
手术部位,并将细胞内细菌输送到血流和内脏器官,最终
目前,没有直接的实验或临床证据表明易感宿主败血症死亡。
然而,我们最近取得了一些潜在的突破性发现:
首先证实了这些模型是针对自溶素(ATL)的抗体有效蛋白质。
诱导金黄色葡萄球菌巨簇形成、调理吞噬作用和保护/存活
小鼠和人类的骨髓炎第二个是铁感应决定簇B(IsdB)最多。
小鼠和人中的免疫显性金黄色葡萄球菌抗原,并且针对 IsdB 的抗体是
与败血症、多器官衰竭和手术部位感染后死亡有关。8,13 在这里,我们
提议:1)阐明抗 IsdB 介导的脓毒症死亡的分子机制,2)验证
PJI 患者中“易感”抗 Isd 与“保护性”抗 Atl 免疫蛋白质组,以及 3) 扩展了这一点
骨免疫学阐明表皮葡萄球菌和路邓葡萄球菌的免疫蛋白质组。
实现这些目标的方法体现在三个具体目标中,我们将在目标 1 中阐明。
抗 IsdB 和相关抗 IsdA 和抗 IsdH 抗体介导的脓毒症机制。
我们还将完成一项临床试点研究,以证明骨髓炎。
死于金黄色葡萄球菌败血性死亡的患者具有高抗 ISD 滴度和特洛伊木马
在目标 2 中,我们将测试免疫蛋白质组假设。
通过将抗 Isd 和抗 Atl 滴度与 300 名接受 2- 治疗的 PJI 患者的临床结果相关联
使用我们的多重 Luminex 检测进行阶段修复手术,并定义脆弱性:保护指数
在目标 3 中,我们将扩展我们对哺乳动物宿主的了解。
通过对表皮葡萄球菌和葡萄球菌进行多重 Luminex 检测,对葡萄球菌作出反应。
Lugdunensis,并使用它们筛选小鼠和 PJI 患者的血清,就像我们对金黄色葡萄球菌所做的那样。
!
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Edward M. Schwarz其他文献
A semi-automated cell tracking protocol for quantitative analyses of neutrophil swarming to sterile and S. aureus contaminated bone implants in a mouse femur model
一种半自动细胞追踪方案,用于定量分析小鼠股骨模型中中性粒细胞聚集到无菌和金黄色葡萄球菌污染的骨植入物
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:3.7
- 作者:
Sashank Lekkala;Youliang Ren;Jason Weeks;Kevin Lee;A. J. H. Tay;Bei Liu;Thomas Xue;Joshua Rainbolt;Chao Xie;Edward M. Schwarz;Shu - 通讯作者:
Shu
The 2023 Orthopedic Research Society's international consensus meeting on musculoskeletal infection: Summary from the in vitro section
2023年骨科研究会肌肉骨骼感染国际共识会议:体外部分总结
- DOI:
10.1002/jor.25774 - 发表时间:
2023-12-25 - 期刊:
- 影响因子:0
- 作者:
Noreen J. Hickok;Bingyun Li;Ebru Oral;S. Zaat;David A. Armbruster;Gerald J. Atkins;Antonia F. Chen;Débora C. Coraça‐Huber;Tianhong Dai;Edward M. Greenfield;Rajendra Kasinath;Matthew Libera;Cláudia N H Marques;T. Fintan Moriarty;K. Scott Phillips;Kapil Raghuraman;Dacheng Ren;Lia Rimondini;K. Saeed;Thomas P. Schaer;Edward M. Schwarz;Christopher Spiegel;P. Stoodley;Vi Khanh Truong;Shao‐Ting Jerry Tsang;B. Wildemann;A. R. Zelmer;A. Zinkernagel - 通讯作者:
A. Zinkernagel
Loss of the PGE2 Receptor EP1 enhances bone acquisition, which protects against age and ovariectomy-induced impairments in bone strength
PGE2 受体 EP1 的缺失会增强骨获取,从而保护
- DOI:
- 发表时间:
- 期刊:
- 影响因子:4.1
- 作者:
Edward M. Schwarz;Jennifer H. Jonason;Alayna E. Loiselle;Regis J. O’Keefe - 通讯作者:
Regis J. O’Keefe
2023 International Consensus Meeting on musculoskeletal infection: Summary from the treatment workgroup and consensus on treatment in preclinical models
2023国际肌肉骨骼感染共识会议:治疗工作组总结和临床前模型治疗共识
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:2.8
- 作者:
Jessica A. Jennings;Jacobus J. Arts;Ezzuddin Abuhussein;V. Alt;Nicholas Ashton;Susanne Baertl;Sanjib Bhattacharyya;Jarrett D. Cain;Yogita Dintakurthi;P. Ducheyne;Hannah Duffy;Robert Falconer;Malley A Gautreaux;Sofia Gianotti;John L. Hamilton;Annika Hylen;Sanne Hoogstraten;Andres Libos;Adrienn Markovics;Vuyisa Mdingi;Emily C Montgomery;Mario Morgenstern;W. Obremskey;L. Priddy;Jermiah Tate;Youliang Ren;Benjamin Ricciardi;Luke J Tucker;Jason Weeks;N. Vanvelk;Dustin Williams;Chao Xie;N. Hickok;Edward M. Schwarz;T. Fintan Moriarty - 通讯作者:
T. Fintan Moriarty
Tumor necrosis factor prevents alendronate-induced osteoclast apoptosis in vivo by stimulating Bcl-xL expression through Ets-2.
肿瘤坏死因子通过 Ets-2 刺激 Bcl-xL 表达,防止阿仑膦酸钠诱导的破骨细胞凋亡。
- DOI:
10.1002/art.21236 - 发表时间:
2005-09-01 - 期刊:
- 影响因子:0
- 作者:
Qian Zhang;I. R. Badell;Edward M. Schwarz;K. Boulukos;Z. Yao;Brendan F. Boyce;Lianping Xing - 通讯作者:
Lianping Xing
Edward M. Schwarz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Edward M. Schwarz', 18)}}的其他基金
Quantifying the Race for the Surface via IV-MLSM
通过 IV-MLSM 量化表面竞赛
- 批准号:
10455337 - 财政年份:2022
- 资助金额:
$ 32.45万 - 项目类别:
Rochester Resource-Based Center for Bone, Muscle and Orthopaedic Research (ROCSTARR) (Overall Application)
罗切斯特骨骼、肌肉和骨科研究资源中心 (ROCSTARR)(整体申请)
- 批准号:
10544989 - 财政年份:2022
- 资助金额:
$ 32.45万 - 项目类别:
Quantifying the Race for the Surface via IV-MLSM
通过 IV-MLSM 量化表面竞赛
- 批准号:
10618393 - 财政年份:2022
- 资助金额:
$ 32.45万 - 项目类别:
Rochester Resource-Based Center for Bone, Muscle and Orthopaedic Research (ROCSTARR) (Overall Application)
罗切斯特骨骼、肌肉和骨科研究资源中心 (ROCSTARR)(整体申请)
- 批准号:
10232833 - 财政年份:2022
- 资助金额:
$ 32.45万 - 项目类别:
Center of Research Translation on the Osteoimmunology of Bone Infection
骨感染骨免疫学研究翻译中心
- 批准号:
9370633 - 财政年份:2017
- 资助金额:
$ 32.45万 - 项目类别:
Center of Research Translation on the Osteoimmunology of Bone Infection
骨感染骨免疫学研究翻译中心
- 批准号:
10247748 - 财政年份:2017
- 资助金额:
$ 32.45万 - 项目类别:
Center of Research Translation on the Osteoimmunology of Bone Infection (CoRTOBI)
骨感染骨免疫学研究翻译中心 (CoRTOBI)
- 批准号:
10402963 - 财政年份:2017
- 资助金额:
$ 32.45万 - 项目类别:
相似国自然基金
基于抗原抗体相互作用的抗体定向虚拟设计与筛选
- 批准号:32370697
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
原位疫苗新策略:抗体偶联仿生ROS纳米酶增强巨噬细胞吞噬及抗原交叉呈递效应
- 批准号:32371454
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
靶向CLDN18.2抗体的抗原结合特性对CAR-T抗肿瘤活性的调控机制
- 批准号:82303716
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
CD40-CD154共刺激信号介导的TD/TI抗原诱导罗非鱼抗体分泌细胞形成机制的比较研究
- 批准号:32303044
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗变构/单体形式的C反应蛋白关键抗原表位199-206抗体在狼疮性肾炎小管间质病变中的作用机制及其靶向治疗研究
- 批准号:82300829
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Basic and Translational Mechanisms of Alloimmunization to RBC Transfusion. Project 3
红细胞输注同种免疫的基本和转化机制。
- 批准号:
10711670 - 财政年份:2023
- 资助金额:
$ 32.45万 - 项目类别:
Genetic and molecular mechanisms of Xbp-1 mediated salivary gland development and differentiation
Xbp-1介导唾液腺发育和分化的遗传和分子机制
- 批准号:
10678146 - 财政年份:2023
- 资助金额:
$ 32.45万 - 项目类别:
Shigella Conjugate Vaccine (SCV4) Development, Characterization, and Pre-clinical Evaluation
志贺氏菌结合疫苗 (SCV4) 的开发、表征和临床前评估
- 批准号:
10704325 - 财政年份:2023
- 资助金额:
$ 32.45万 - 项目类别:
Characterizing antibody responses to HIV-1 vaccination in next-generation immune humanized mice
表征下一代免疫人源化小鼠对 HIV-1 疫苗接种的抗体反应
- 批准号:
10673292 - 财政年份:2023
- 资助金额:
$ 32.45万 - 项目类别: